In summary, the knockdown of ANT2 using ANT2 shRNA systems in breast cancer models induces apoptotic cell death followed by ATP depletion, G1 stage arrest and the disruption of mitochondrial membrane potentials in vitro and tumor regression in vivo. The gene discussed is SLC25A5; the disease is breast cancer.